Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gilbert Chaaya Youssef, M.D.

Concepts (14)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Gilbert Youssef's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Gilbert Youssef has written about over time.
Oncolytic Virotherapy, 1 publications between 2019 and 2019, average publication date September 2019. Pyridones, 1 publications between 2019 and 2019, average publication date September 2019. Pyrimidinones, 1 publications between 2019 and 2019, average publication date September 2019. Glioma, 2 publications between 2019 and 2020, average publication date January 2020. Brain Neoplasms, 3 publications between 2019 and 2020, average publication date April 2020. Humans, 3 publications between 2019 and 2020, average publication date April 2020. Astrocytoma, 1 publications between 2020 and 2020, average publication date May 2020. Isocitrate Dehydrogenase, 1 publications between 2020 and 2020, average publication date May 2020. Mutation, 1 publications between 2020 and 2020, average publication date May 2020. Young Adult, 1 publications between 2020 and 2020, average publication date May 2020. Animals, 1 publications between 2020 and 2020, average publication date October 2020. Glioblastoma, 1 publications between 2020 and 2020, average publication date October 2020. Immunotherapy, 1 publications between 2020 and 2020, average publication date October 2020. Mice, 1 publications between 2020 and 2020, average publication date October 2020.

To see the data from this visualization as text, click here.
Youssef's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (14)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.